PubMed · 1996 · 31 citations · 0 references
MedicineHematologyInfectious DiseasesStem Cell TransplantationTransplant ImmunologyTransplant SurgeryAutologous Stem Cell TransplantationBlood ParasitesHematopoietic Stem Cell TransplantationMalariaTransplant ComplicationsTransplant Infectious ComplicationsMalaria AnemiaMalaria ImmunologyMalaria ParasitesMalaria PathologyPlasmodium FalciparumPlasmodium VivaxSurvival After Autologous Transplantation
We report the case of unusually early infection by Plasmodium vivax after autologous bone marrow transplantation in a 20-year-old female from Bangladesh affected by acute myelogenous leukemia in first complete remission (CR) who underwent autologous bone marrow transplantation in our center. During the aplastic phase she became febrile; broad spectrum antibiotics and antifungal therapy were without effect. Blood smears were examined and Plasmodium vivax was detected despite a very low number of red cells infected. Cloroquine therapy for 3 days was given followed by primaquine for 2 weeks in order to avoid possible cloroquine resistance. Fever disappeared within 48 h from initial treatment and the patient was discharged having completely recovered at day +30. Primary malaria infection in non-endemic areas is a very rare event. In this particular case, after excluding primary infection or blood transfusion-mediated infection, malaria was attributed to a recrudescence of a primary unidentified infection.